InMed Announces CVR Distribution Record Date in Connection with Proposed Merger

InMed Pharmaceuticals fixed November 5, 2026 as the CVR Distribution Record Date for the distribution of contingent value rights to shareholders under its pending merger with Mentari Therapeutics. CVR distribution is conditional on shareholder approval of the Return of Capital Proposal at the November 4, 2026 annual general and special meeting; the Form S-4 was declared effective by the SEC on October 1, 2026. Shareholders will receive one CVR per common share held at the record date, with buyers on November 5 not expected to qualify and no CVR entitlement for option-surrender shares.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.